Press
releases

Nov 20, 2023

Ultragenyx to Participate at Investor Conferences in November

Read more

Nov 17, 2023

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Read more

Nov 07, 2023

Ultragenyx to Participate in the Jefferies London Healthcare Conference

Read more

Nov 02, 2023

Ultragenyx Reports Third Quarter 2023 Financial Results and Corporate Update

Read more

Oct 26, 2023

Ultragenyx to Host Conference Call for Third Quarter 2023 Financial Results and Corporate Update

Read more

Oct 23, 2023

Ultragenyx Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Read more

Oct 20, 2023

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Read more

Oct 18, 2023

Ultragenyx Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

Read more

Oct 17, 2023

Ultragenyx Announces Proposed Public Offering of Common Stock

Read more

Oct 16, 2023

Ultragenyx Announces Program and Pipeline Updates at Analyst Day Including Interim Data from Ongoing Studies in Osteogenesis Imperfecta (OI), Angelman Syndrome (AS) and Wilson Disease

Read more